Open AccessHigh seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV – but HIV viremia matters?
Author(s) -
Laura Gianserra,
Maria Gabriella Donà,
Eugenia Giuliani,
C Stingone,
Martina Pontone,
Anna Rita Buonomini,
Massimo Giuliani,
Fulvia Pimpinelli,
Aldo Morrone,
Alessandra Latini
Publication year - 2022
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000003239
Subject(s) - medicine , viremia , immunogenicity , regimen , vaccination , seroconversion , cart , hiv vaccine , population , antibody , immunology , vaccine trial , mechanical engineering , environmental health , engineering